66
Participants
Start Date
November 30, 2012
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Dorzolamide 2% TID or brinzolamide 1% TID
"Dosing of all medications will be based upon standard of care. Standard dosing for the treatment of pediatric and adult patients with XLRS is as follows:~* Topical dorzolamide 2% three times per day~* Topical brinzolamide 1% three times per day"
University of Michigan Kellogg Eye Center, Ann Arbor
Retina Foundation of the Southwest, Dallas
Casey Eye Institute, Oregon Health and Sciences University, Portland
Lead Sponsor
Foundation Fighting Blindness
OTHER
Beacon Therapeutics
INDUSTRY